A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study

European Urology

Volumn 56, Issue 3, 2009, Pages 544-551

  Wagenlehner, Florian M E ^a   Schneider, Henning ^a   Ludwig, Martin ^a   Schnitker, Jörg ^b   Brähler, Elmar ^c   Weidner, Wolfgang ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Institute for Applied Statistics   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cernilton; Chronic pelvic pain syndrome; Chronic prostatitis symptom index; Inflammatory chronic pelvic pain syndrome; Prostatitis syndrome

Indexed keywords

CERNITIN; PLACEBO;

ADULT; ARTICLE; CHRONIC PROSTATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LEUKOCYTE; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL INSTITUTE OF HEALTH CHRONIC PROSTATITIS SYMPTOM INDEX; PAIN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUALITY; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; PROSTATITIS; SECALE CEREALE; YOUNG ADULT;

EID: 67651054995     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.05.046     Document Type: Article

References (34)

1. Schaeffer A.J. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 355 (2006) 1690-1698
2. Schaeffer AJ, Anderson RU, Krieger JN, et al. Consensus statement on prostatitis. The assessment and management of male pelvic pain syndrome, including prostatitis. In: 6th International Conference on New Developments in Prostate Cancer and Prostate Diseases, ed. MLUTD. Paris, France: Health Publications; 2006. p. 343-75.
3. Krieger J.N., Nyberg Jr. L., and Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA 282 (1999) 236-237
4. Nickel J.C., Krieger J.N., McNaughton-Collins M., et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359 (2008) 2663-2673
5. Rugendorff E.W., Weidner W., Ebeling L., and Buck A.C. Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 71 (1993) 433-438
6. Shoskes D.A. Phytotherapy in chronic prostatitis. Urology 60 (2002) 35-37
7. Buck A.C., Cox R., Rees R.W., Ebeling L., and John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Br J Urol 66 (1990) 398-404
8. Buck A.C., Rees R.W., and Ebeling L. Treatment of chronic prostatitis and prostatodynia with pollen extract. Br J Urol 64 (1989) 496-499
9. Kamijo T., Sato S., and Kitamura T. Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats. Prostate 49 (2001) 122-131
10. Asakawa K., Nandachi N., Satoh S., et al. Effects of cernitin pollen-extract (Cernilton) on inflammatory cytokines in sex-hormone-induced nonbacterial prostatitis rats [in Japanese]. Hinyokika Kiyo 47 (2001) 459-465
11. Loschen G., and Ebeling L. Inhibition of arachidonic acid cascade by extract of rye pollen [in German]. Arzneimittelforschung 41 (1991) 162-167
12. Talpur N., Echard B., Bagchi D., Bagchi M., and Preuss H.G. Comparison of saw palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Mol Cell Biochem 250 (2003) 21-26
13. Monden K., Tsugawa M., Ninomiya Y., Ando E., and Kumon H. A Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI, Okayama version) and the clinical evaluation of cernitin pollen extract for chronic non-bacterial prostatitis [in Japanese]. Nippon Hinyokika Gakkai Zasshi 93 (2002) 539-547
14. Propert K.J., Alexander R.B., Nickel J.C., et al. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 59 (2002) 870-876
15. Hochreiter W., Ludwig M., Weidner W., et al. National Institutes of Health (NIH) Chronic Prostatitis Symptom Index. The German version [in German]. Urologe A 40 (2001) 16-17
16. Badia X., Garcia-Losa M., and Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol 31 (1997) 129-140
17. Myrtek M. Life satisfaction, illness behaviour, and rehabilitation outcome: results of a one year follow-up study with cardiac patients. Int J Rehabil Res 10 (1987) 373-382
18. Fahrenberg J., Myrtek M., Schumacher J., and Brähler E. Fragebogen zur Lebenszufriedenheit (FLZ). EBT Handanweisung (2000), Hogrefe, Göttingen, Germany
19. Meares E.M., and Stamey T.A. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5 (1968) 492-518
20. Bauer P., and Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 50 (1994) 1029-1041
21. Nickel J.C., Pontari M., Moon T., et al. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 169 (2003) 1401-1405
22. Bjerklund Johansen T.E., Gruneberg R.N., Guibert J., et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 34 (1998) 457-466
23. Tuǧcu V., Taşçi{dotless} A.I., Fazlioǧlu A., et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51 (2007) 1113-1118
24. Naber K.G., Bergman B., Bishop M.C., et al. EAU guidelines for the management of urinary and male genital tract infections: Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol 40 (2001) 576-588
25. Capodice J.L., Bemis D.L., Buttyan R., Kaplan S.A., and Katz A.E. Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid Based Complement Alternat Med 2 (2005) 495-501
26. Lee C.B., Ha U.S., Lee S.J., Kim S.W., and Cho Y.H. Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol 24 (2006) 55-60
27. Kaplan S.A., Volpe M.A., and Te A.E. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 171 (2004) 284-288
28. Shoskes D.A., Zeitlin S.I., Shahed A., and Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54 (1999) 960-963
29. Shoskes D.A. Phytotherapy and other alternative forms of care for the patient with prostatitis. Curr Urol Rep 3 (2002) 330-334
30. Nickel J.C. Role of alpha1-blockers in chronic prostatitis syndromes. BJU Int 101 Suppl 3 (2008) 11-16
31. Penna G., Mondaini N., Amuchastegui S., et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 51 (2007) 524-533
32. Ludwig M., Steltz C., Huwe P., Schäffer R., Altmannsberger M., and Weidner W. Immunocytological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage. Eur Urol 39 (2001) 277-282
33. Schneider H., Ludwig M., Horstmann A., Schnitker J., and Weidner W. The efficacy of Cernilton in patients with chronic pelvic pain syndrome (CP/CPPS) type NIH IIIA: a randomized, prospective, double-blind, placebo controlled study. J Urol 175 (2006) 34 abstract 105
34. Wagenlehner F.M.E., Schneider H., Ludwig M., Horstmann A., Schnitker J., and Weidner W. Long term efficacy of Cernilton in patients with chronic prostatitis/chronic pelvic pain syndrome type NIH IIIA. Eur Urol Suppl 8 (2009) 260 abstract 559